21261/34347US=28 / Urologia
Elson PJ. Prognostic factors for survival in metastatic renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 307-22. ISBN 978-1-58829-251-3.

SOBREVIVENCIA NO CARCINOMA DE CELULAS RENAIS METASTATICO


21262/34347US=28 / Urologia
Elson PJ. Prognostic factors for survival in metastatic renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 307-22. ISBN 978-1-58829-251-3.

SOBREVIVENCIA NO CARCINOMA DE CELULAS RENAIS METASTATICO


21263/34347US=28 / Biol/Mol
Keane MP, Belperio JA, Strieter RM. Chemokines in angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 155-70. ISBN 978-1-58829-870-6.

QUIMIOCINAS NA ANGIOGENESE; RECEPTOR QUIMIOCINAS; ANGIOGENESE; CANCER


21264/34347US=28 / Biol/Mol
Kabayashi H, DeBush LM, Lin PC. Angiopoietin/Tie2 signaling regulates tumor angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 171-87. ISBN 978-1-58829-870-6.

ANGIOPOIETINA; AMARRAR; ANGIOGENESE TUMORAL; VEGF; CANCER; METASTASE


21265/34347US=28 / Urologia
Majhail NS, Bukowski RM. Fuctional imaging of renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 323-33. ISBN 978-1-58829-251-3.

IMAGIOLOGIA FUNCIONAL DE CARCINOMA DE CELULAS RENAIS; F-18 FLUORODEOXIGLICOSE; TOMOGRAFIA POR EMISSAO DE POSITRONS


21266/34347US=28 / Biol/Mol
Kalva SP, Namasivayam S, Kabayashi H, DeBush LM, Lin PC. Imaging angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 189-203. ISBN 978-1-58829-870-6.

IMAGEM ANGIOGENESE; PERFUSAO CT; PERFUSAO MRI; COM CONTRASTE DE ULTRA-SOM; ANGIOGENESE


21267/34347US=28 / Biol/Mol
Nagy JA, Fu Y, Dvorak AM, Dvorak HF. Tumor blood vessels. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 205-24. ISBN 978-1-58829-870-6.

VEGF-A; VASOS SANGUINEOS TUMORAIS; ANGIOGENESE; ARTERIOGENESE; VENOGENESIS


21268/34347US=28 / Urologia
Orris BG, Flanigan RC. Nephrectomy in patients with metastatic renal cell carcinoma: clinical and biologic effects. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 335-53. ISBN 978-1-58829-251-3.

NEFRECTOMIA; CARCINOMA DE CELULAS RENAIS METASTATICO. PACIENTES COM NEFRECTOMIA


21269/34347US=28 / Urologia
Oliver T, Powles T, Narrgund V, Berney D. Spontaneous regression of renal cell carcinoma and the role of prognostic factors. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 355-66. ISBN 978-1-58829-251-3.

REGRESSAO ESPONTANEA DE CARCINOMA; CARCINOMA DE CELULAS RENAIS; PROGNOSTICOS; PARAMETROS SANGUINEOS PERIFERICOS


21270/34347US=28 / Urologia
Jin JO, Stadler WM. Chemotherapy for metastatic clear-cell renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 385-97. ISBN 978-1-58829-251-3.

QUIMIOTERAPIA PARA CARCINOMA DE CELULAS RENAIS DE CELULAS CLARAS; AGENTE UNICO DE QUIMIOTERAPIA; TERAPIA HORMONAL; TERAPIA COMBINADA CHEMOHORMONAL


21271/34347US=28 / Urologia
Ronnem EA, George S, Bukowski RM, Motzer RJ. Signal transduction inhibitors in renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 399-413. ISBN 978-1-58829-251-3.

INIBIDORES DE TRANSDUCAO DE SINAL EM CARCINOMA DE CELULAS RENAIS; CARCINOMA DE CELULAS RENAIS METASTATICO; PAPILAR CARCINOMA DE CELULAS RENAIS


21272/34347US=28 / Biol/Mol
Pytowshi B. Lymphatic system in the pathology of cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 225-41. ISBN 978-1-58829-870-6.

SISTEMA LINFATICO NA PATOLOGIA DO CANCRO; CELULAS ENDOTELIAIS; LINFA; LINFONODOS; VASOS LINFATICOS; CANCER; DESENVOLVIMENTO; METASTASE


21273/34347US=28 / Biol/Mol
Maharaj ASR, D'Amore PA. VEGF in the adult. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 245-59. ISBN 978-1-58829-870-6.

VEGF; ANGIOGENESE; PRE-ECLAMPSIA; TERAPIA ANTI-ANGIOGENICA; BEVACIZUMAB; CELULAS ENDOTELIAIS


21274/34347US=28 / Biol/Mol
Jain RK, Batchelor TT, Duda DG, Willett CG. Normalization of tumor vasculature and microenvironment. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 261-76. ISBN 978-1-58829-870-6.

ANGIOGENESE; BIOMARCADOR; MRI; NORMALIZACAO; VEGF; TUMOR


21275/34347US=23 / Câncer
Hayat MA. Breast cancer: an introduction. In: ___. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 1-3. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. INTRODUCAO


21276/34347US=23 / Câncer
Zheng B. Breast cancer: computer-aided detection. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 5-27. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. DETECCAO; COMPUTADOR; CAD; DIAGNOSTICO AUXILIADO POR COMPUTADOR


21277/34347US=23 / Câncer
Hisaoka M, Hamada T. Sebaceous carcinoma of the breast: clinicopathologic features. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 29-32. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMA SEBACEO DA MAMA; CARACTERISTICAS CLINICO-PATOLOGICAS


21278/34347US=28 / Biol/Mol
Kerbel RS, Emmenegger U, Folkins C, Munoz R, Shaked Y. Metronomic low-dose antiangiogenic chemotherapy in mice and man. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 277-96. ISBN 978-1-58829-870-6.

BAIXA DOSE DE QUIMIOTERAPIA; ANGIOGENESE TUMORAL; TERAPIA ANTIANGIOGENICA; ENSAIOS CLINICOS; CELULAS PROGENITORAS ENDOTELIAIS; VEGF; METASTASE; CANCER DE MAMA; CANCRO DO OVARIO; CICLOFOSFAMIDA


21279/34347US=28 / Biol/Mol
Siemann DW, Horsman MR. Small-molecule vascular disrupting agents in cancer therapy. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 297-310. ISBN 978-1-58829-870-6.

21280/34347US=23 / Câncer
Bach-Gansmo T, Tobin D. Breast cancer: detection by in-vivo imaging of angiogenesis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 33-42. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; ANGIOGENESE IN VIVO; INTEGRINAS; CINTILOGRAFIA; TC-NC100692; EXPERIENCIA CLINICA INICIAL; RAIOS GAMA; CAMARA GAMA


Primeira | Anterior | Próxima | Última